APGE
Apogee Therapeutics, Inc.
135.10$
+0.0%
vs. previous close
Closing price · As of: Sep 3, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 99.3% | 70.3% | 79.1% | |
| 99.9% | 29.5% | 18.8% | 14.0% | |
| 99.9% | 98.5% | 69.1% | 77.9% | |
| – | 0.3% | 0.6% | 0.6% | |
| 6.6% | 5.4% | 4.9% | 3.5% | |
| 6.6% | 5.1% | 3.8% | 3.0% | |
| – | 0.3% | 0.4% | 0.4% | |
| 0.3% | 0.5% | 0.1% | 0.1% | |
| 93.4% | 94.6% | 95.1% | 96.5% | |
| -26.2% | -30.8% | -40.6% | -59.9% | |
| 33.3% | 12.6% | 7.3% | 6.5% |
Data as of: September 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.